Table 2.
Descriptive statistics of the study population.
| Variable |
Median
Pre-HAART CD4 (IQR) (cells/mm3) |
Median
Pre-HAART CD8 (IQR) (cells/mm3) |
Mean
Pre-HAART CD4/CD8 (SD) |
Median
Post-HAART CD4 (IQR) (cells/mm3) |
Median
Post-HAART CD8 (IQR) (cells/mm3) |
Mean
Post-HAART CD4/CD8 (SD) |
|
|---|---|---|---|---|---|---|---|
| Gender | Male | 249.5 (114.5-366) |
811 (554-1335) |
0.31 (0.36) | 427.85 (227.85-577.22) |
736.45 (542.25-1073.15) |
0.63 (0.54) |
| Female | 284 (191.75-414) |
944.5 (680.25-1143.75) |
0.35 (0.22) | 454.2 (329.25-558.35) |
694.15 (533.65-1022.575) |
0.77 (0.53) | |
| Marital status | Single | 325.5 (259.25-448.25) |
787 (573-1210) |
0.45 (0.45) | 494.65 (365.82-611.57) |
717.4 (573.4-957.8) |
0.72 (0.47) |
| Married | 222 (117.78-351) |
914 (566.5-1158) |
0.27 (0.20) | 387.3 (229.35-534.5) |
713.7 (524.6-1085.95) |
0.65 (0.49) | |
| Widowed | 331 (222.5-393) |
1103 (937.5-1687) |
0.30 (0.21) | 385.6 (246.75-420.35) |
678.9 (463.45-1313.25) |
0.76 (0.75) | |
| Separated/divorced | 346 (243-436.75) |
1168 (927.25-1790) |
0.31 (0.14) | 587 (327.5-749) |
1055 (639.4-1227) |
0.84 (0.92) | |
| Duration of HAART | 6 months | 310.5 (174.75-453.75) |
922 (641.5-1366.25) |
0.34 (0.20) | 448.5 (310.85-535.7) |
728.5 (530.18-1194.13) |
0.67 (0.48) |
| 12 months | 257 (134.5-371.5) |
988 (630-1224.25) |
0.31 (0.23) | 410 (216-584.4) |
786.7 (646.1-1108) |
0.61 (0.59) | |
| 18 months | 275.5 (81.45-346.75) |
843 (561-1117.25) |
0.34 (0.42) | 432 (282-581) |
647 (523-905) |
0.78 (0.53) | |
CD4: Cluster of differentiation 4; CD8: Cluster of differentiation 8; HAART: Highly active antiretroviral therapy; IQR: Interquartile range; SD: Standard deviation.